To assess whether NQO1 IHC would be a reliable predictor for KEAP1/NFE2L2 mutation status, we stained and semi-quantitatively assessed 232 NSCLC of the Cologne cohort for which enough residual FFPE tissue was available (Fig. 1A). This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.